Published in Chest on September 21, 2007
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med (2011) 2.64
Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc (2015) 1.93
Socioeconomic status, race and COPD health outcomes. J Epidemiol Community Health (2009) 1.54
Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD. Chest (2016) 1.45
Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res (2011) 1.36
Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.36
The accuracy and efficiency of electronic screening for recruitment into a clinical trial on COPD. Respir Med (2011) 1.34
CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest (2014) 1.17
Prediction of acute respiratory disease in current and former smokers with and without COPD. Chest (2014) 1.15
Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD. Thorax (2015) 1.12
Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis (2013) 1.11
Implementing chronic care for COPD: planned visits, care coordination, and patient empowerment for improved outcomes. Int J Chron Obstruct Pulmon Dis (2011) 1.04
Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis (2010) 1.01
Using modeling to inform patient-centered care choices at the end of life. J Comp Eff Res (2013) 0.95
Palliative care in COPD: an unmet area for quality improvement. Int J Chron Obstruct Pulmon Dis (2015) 0.93
A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem. J Community Hosp Intern Med Perspect (2012) 0.93
Influence of diet and obesity on COPD development and outcomes. Int J Chron Obstruct Pulmon Dis (2014) 0.93
Hospitalization rates and survival associated with COPD: a nationwide Danish cohort study. Lung (2010) 0.91
Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost. Cost Eff Resour Alloc (2013) 0.91
Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD. Int J Chron Obstruct Pulmon Dis (2013) 0.90
The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study. BMJ Open (2014) 0.89
A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis (2015) 0.88
Pulmonary hypertension in a stable community-based COPD population. Lung (2011) 0.87
Asthma, airflow limitation and mortality risk in the general population. Eur Respir J (2014) 0.87
Patient-Centered Medical Home in chronic obstructive pulmonary disease. J Multidiscip Healthc (2011) 0.79
Outcomes associated with acute exacerbations of chronic obstructive pulmonary disorder requiring hospitalization. Lung India (2015) 0.77
IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2015) 0.77
Physical activity assessed in routine care predicts mortality after a COPD hospitalisation. ERJ Open Res (2016) 0.77
Utility of the combination of serum highly-sensitive C-reactive protein level at discharge and a risk index in predicting readmission for acute exacerbation of COPD. J Bras Pneumol (2014) 0.77
Role of Tiotropium in Reducing Exacerbations of Chronic Obstructive Pulmonary Disease When Combined With Long-Acting β2 -Agonists and Inhaled Corticosteroids: The OUTPUL Study. J Clin Pharmacol (2016) 0.77
Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2016) 0.77
Management of patients during and after exacerbations of chronic obstructive pulmonary disease: the role of primary care physicians. Int J Gen Med (2011) 0.76
Hypoxia-induced pulmonary arterial hypertension augments lung injury and airway reactivity caused by ozone exposure. Toxicol Appl Pharmacol (2016) 0.75
Long-term integrated telerehabilitation of COPD Patients: a multicentre randomised controlled trial (iTrain). BMC Pulm Med (2016) 0.75
Feasibility of a telecare solution for patients admitted with COPD exacerbation: screening data from a pulmonary ward in a university hospital. Eur Clin Respir J (2014) 0.75
Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD. Chest (2016) 0.75
Assisted ventilation in COPD - association between previous hospitalizations and mortality. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Heart failure and respiratory hospitalizations are reduced in patients with heart failure and chronic obstructive pulmonary disease with the use of an implantable pulmonary artery pressure monitoring device. J Card Fail (2014) 0.75
Initial risk assessment for pulmonary hypertension in patients with COPD. Lung (2011) 0.75
Understanding COPD hospitalizations: the devil is always in the details! Chest (2007) 0.75
Acute Exacerbations and Lung Function Loss in Smokers With and Without COPD. Am J Respir Crit Care Med (2016) 0.75
Implications of the pulmonary artery to ascending aortic ratio in patients with relatively mild chronic obstructive pulmonary disease. J Thorac Dis (2016) 0.75
Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Prognostic utility of admission cell-free DNA levels in patients with chronic obstructive pulmonary disease exacerbations. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med (2017) 0.75
Acute exacerbations of COPD: risk factors for failure and relapse. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med (2010) 6.19
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med (2013) 4.49
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol (2010) 4.38
Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med (2007) 3.95
Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med (2006) 3.71
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
Sex differences in severe pulmonary emphysema. Am J Respir Crit Care Med (2007) 2.77
Obesity and asthma. Am J Respir Crit Care Med (2006) 2.43
Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med (2011) 2.06
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.98
Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med (2007) 1.94
A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med (2012) 1.75
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2015) 1.70
Gender differences of airway dimensions in anatomically matched sites on CT in smokers. COPD (2011) 1.66
Impact of race on asthma treatment failures in the asthma clinical research network. Am J Respir Crit Care Med (2011) 1.63
Factors influencing models of end-of-life care in nursing homes: results of a survey of nursing home administrators. J Palliat Med (2004) 1.53
Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma. Am J Respir Crit Care Med (2014) 1.44
Regional variation in mortality and subsequent hospitalization of nursing residents with heart failure. J Am Med Dir Assoc (2010) 1.41
The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med (2013) 1.36
Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res (2011) 1.36
Oxygen therapy for patients with COPD: current evidence and the long-term oxygen treatment trial. Chest (2010) 1.31
Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration (2010) 1.22
Airway fibroblasts exhibit a synthetic phenotype in severe asthma. J Allergy Clin Immunol (2005) 1.10
Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res (2010) 1.07
Complement activation in a model of chronic fatigue syndrome. J Allergy Clin Immunol (2003) 1.05
Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med (2008) 1.05
Site of death in the hospital versus nursing home of Medicare skilled nursing facility residents admitted under Medicare's Part A Benefit. J Am Geriatr Soc (2004) 1.04
Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances. J Allergy Clin Immunol (2013) 1.01
Obesity impairs apoptotic cell clearance in asthma. J Allergy Clin Immunol (2012) 0.98
Associations among nurse and certified nursing assistant hours per resident per day and adherence to guidelines for treating nursing home-acquired pneumonia. J Gerontol A Biol Sci Med Sci (2008) 0.97
Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 0.96
Wildfire smoke and respiratory symptoms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol (2005) 0.96
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast. J Asthma (2010) 0.95
Racial differences in CT phenotypes in COPD. COPD (2013) 0.95
Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest (2005) 0.95
Obesity and asthma disease phenotypes. Curr Opin Allergy Clin Immunol (2012) 0.95
Inhaled corticosteroids in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2007) 0.94
Asthma outcomes: symptoms. J Allergy Clin Immunol (2012) 0.93
Vitamin D in asthma: panacea or true promise? J Allergy Clin Immunol (2010) 0.93
Obesity and pulmonary function testing. J Allergy Clin Immunol (2005) 0.93
Chronic obstructive pulmonary disease: a concise review. Med Clin North Am (2011) 0.92
Pulmonary rehabilitation: WHAT WE KNOW AND WHAT WE NEED TO KNOW. J Cardiopulm Rehabil Prev (2009) 0.89
Quantifying posthospital care transitions in older patients. J Am Med Dir Assoc (2004) 0.89
The development of a patient-reported outcome measure for assessing nighttime symptoms of chronic obstructive pulmonary disease. Health Qual Life Outcomes (2013) 0.89
Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care (2013) 0.89
Patient-centered adherence intervention after acute coronary syndrome hospitalization. Circ Cardiovasc Qual Outcomes (2012) 0.89
Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med (2009) 0.88
Attributions about cause of illness in chronic obstructive pulmonary disease. J Psychosom Res (2010) 0.88
Airway and parenchymal disease in chronic obstructive pulmonary disease are distinct phenotypes. Proc Am Thorac Soc (2006) 0.86
Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans. Curr Med Res Opin (2010) 0.86
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease. Clin Infect Dis (2012) 0.86
Optimizing the 6-min walk test as a measure of exercise capacity in COPD. Chest (2012) 0.86
Neurobehavioral improvement after brief rehabilitation in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2002) 0.85
A multifaceted intervention to implement guidelines did not affect hospitalization rates for nursing home-acquired pneumonia. J Am Med Dir Assoc (2010) 0.84
Recommendations of the 6th long-term oxygen therapy consensus conference. Respir Care (2006) 0.83
Impact of a multidisciplinary intervention on antibiotic use for nursing home-acquired pneumonia. Am J Geriatr Pharmacother (2011) 0.83
P2X7-regulated protection from exacerbations and loss of control is independent of asthma maintenance therapy. Am J Respir Crit Care Med (2012) 0.81
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy. COPD (2012) 0.81
Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD (2014) 0.81
Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics. COPD (2015) 0.80
Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care (2011) 0.80
Impact of NHAP guideline implementation intervention on staff and resident vaccination rates. J Am Med Dir Assoc (2010) 0.80
Predictors of response to tiotropium versus salmeterol in asthmatic adults. J Allergy Clin Immunol (2013) 0.80
Vitamin D and asthma: another dimension. Am J Respir Crit Care Med (2011) 0.80
Sputum induction in COPD--it's safe, so now what do we do? COPD (2006) 0.79
Winter air pollution and disease parameters in advanced chronic obstructive pulmonary disease panels residing in Denver, Colorado. J Allergy Clin Immunol (2005) 0.79
Increased expression of platelet-derived growth factor receptor-beta in airway fibroblasts of severe asthmatics. Chest (2003) 0.78
Interpreting results from clinical trials: understanding minimal clinically important differences in COPD outcomes. COPD (2005) 0.78
Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction. Ann Am Thorac Soc (2014) 0.77
Treatments for COPD. Respir Med (2005) 0.77
One-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPD. Chest (2014) 0.76
Modeling the impact of increased adherence to asthma therapy. PLoS One (2012) 0.76
Improved neurobehavioral functioning in emphysema patients following medical therapy. J Cardiopulm Rehabil Prev (2010) 0.76
Alphabet soup: assessment of dyspnea. COPD (2004) 0.75
Inhaled steroids and outcomes in COPD: progressing beyond FEV1. Chest (2007) 0.75
Inhaled corticosteroids in chronic obstructive pulmonary disease. Ann Intern Med (2003) 0.75
Sequential cognitive skills in emphysema patients following lung volume reduction surgery: a 2-year longitudinal study. J Cardiopulm Rehabil Prev (2011) 0.75
Pulmonary rehabilitation and clinical trial design in patients with severe COPD. COPD (2008) 0.75
Long-term oxygen therapy: whatever happened to transtracheal oxygen? COPD (2009) 0.75
Clinical year in review I: quality improvement for pulmonary and critical care medicine, lung transplantation, rehabilitation for pulmonary and critically ill patients, and sleep medicine. Proc Am Thorac Soc (2012) 0.75
Raising awareness of COPD: a call to action by the readers of COPD. COPD (2007) 0.75
It's about time--directing our attention toward modifying the course of COPD. Respir Med (2008) 0.75
Respiratory Care Training for Safety-Net Primary Care Practices. Fam Med (2015) 0.75
Interleukin-4 and interleukin-13 augment the proliferative effect of dexamethasone on distal lung fibroblasts. Chest (2003) 0.75